- Latest news▼
-
18:00, April 18 Daily Mail: Elderly woman in China gets infected with brain-eating amoeba
-
14:19, April 18 Obesity: exercising before breakfast helps you lose weight faster
-
10:42, April 18 The Conversation: childhood trauma can cause pathological hoarding
-
08:37, April 18 Daily Mail: Satiating food reduces cravings for sweets, nutritionist says
-
18:22, April 17 First Armenian-German Conference entitled “Heart Failure Spring School”
-
08:38, April 17 Why do kids usually recover from COVID-19 more easily than adults?
-
14:37, April 16 Daily Mail: intermittent fasting is not suitable for children and women before their periods
-
16:41, April 15 Cell: in carriers of defective BRCA2 gene, sugar consumption increases cancer risk
-
15:04, April 15 305 cases of measles recorded in Armenia so far in 2024
-
14:38, April 15 Food and Environmental Virology: tea contributes to effective coronavirus control
-
12:41, April 15 Daily Mail: vitamin A, B3 and E supplements can be dangerous
-
10:56, April 15 Diabetes Care: evening physical activity is good for the heart
-
08:27, April 15 Women are more susceptible to blood loss and death during bypass surgery than men, researchers say
-
18:42, April 13 WHO: Nigeria pioneers revolutionary meningitis vaccine
-
16:43, April 13 One-third of women experience menstruation-related migraines, most often during premenopause - study
All materials
Israeli scientists find molecule killing pancreatic cancer cells
Israeli scientists tested the PJ34 molecule on rodents with cancer. The use of the molecule in animals reduced the number of cancer cells by 80-90% in a month due to the initiation of cell suicide.
Traces of cancer disappeared completely in one rodent.
No serious side effects were observed in rodents, since the effect was exclusively on cancer cells, Rossiyskaya Gazeta reported.
Initially, PJ34 was created to treat stroke. However, it was later proved that this molecule significantly slows down the multiplication of cancer cells and leads to their rapid death. Although PJ34 may affect other types of cancer cells, efficacy in treating pancreatic cancer seems to be most relevant.
Pancreatic cancer is the 12th most common cancer in the world and the fourth leading cause of cancer death. This type of cancer often has drug resistance.
Treatment complicates the fact that in about 80% of cases, the diagnosis is made already at the stage of metastasis. Less than 3% of patients with this type of cancer live more than 5 years after diagnosis.
Follow NEWS.am Medicine on Facebook and Twitter
- Video
- Event calendar
- Archive
- Most read
month
week
day
- Pediatrics: Hypoglossal nerve stimulation implant helps with sleep apnea 1353
- Health minister: Simulation educational center will be created, assisted reproductive technology capacity will increase in Armenia 1311
- WHO: Nigeria pioneers revolutionary meningitis vaccine 1164
- One-third of women experience menstruation-related migraines, most often during premenopause - study 1132
- Women are more susceptible to blood loss and death during bypass surgery than men, researchers say 895
- Daily Mail: vitamin A, B3 and E supplements can be dangerous 874
- Food and Environmental Virology: tea contributes to effective coronavirus control 874
- Cell: in carriers of defective BRCA2 gene, sugar consumption increases cancer risk 843
- 305 cases of measles recorded in Armenia so far in 2024 837
- Diabetes Care: evening physical activity is good for the heart 826
- Daily Mail: intermittent fasting is not suitable for children and women before their periods 651
- First Armenian-German Conference entitled “Heart Failure Spring School” 441
- Why do kids usually recover from COVID-19 more easily than adults? 305
- Obesity: exercising before breakfast helps you lose weight faster 282
- The Conversation: childhood trauma can cause pathological hoarding 274
- Find us on Facebook
- Poll